OSTEOPORE LIMITED - Announcements

Market Cap $3.873M Add to my watchlist

Healthcare Medical Instruments & Supplies

Osteopore Limited is an Australia-based medical technology company. The Company is... Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Company’s Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OSX	Letter to Optionholders		13/03/23	152.5KB	Share
OSX	Letter to Ineligible Shareholders		13/03/23	151.86KB	Share
OSX	Proposed issue of securities - OSX		13/03/23	43.84KB	Share
OSX	Letter to Eligible Shareholders		13/03/23	165.99KB	Share
OSX	Non-Renounceable Entitlement Offer Prospectus	PRICE SENSITIVE	13/03/23	655.44KB	Share
OSX	Non-Renounceable Entitlement Offer	PRICE SENSITIVE	13/03/23	225.78KB	Share
OSX	Notice of General Meeting/Proxy Form		02/03/23	985.97KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/23	214.39KB	Share
OSX	Osteopore Advisory Panel of Distinguished Industry Leaders		27/02/23	318.18KB	Share
OSX	Investor Presentation		20/02/23	6.22MB	Share
OSX	OSX Enters Orthopaedic Market in Great Britain		14/02/23	233.78KB	Share
OSX	Activities Update Qtr Ending December 2022 and Appendix 4C	PRICE SENSITIVE	31/01/23	619.31KB	Share
OSX	Appointment of Joint Company Secretary		25/01/23	165.42KB	Share
OSX	Integration of Acquired Business for Higher Sales & Margin	PRICE SENSITIVE	23/01/23	269.81KB	Share
OSX	Cleansing Notice		04/01/23	222.94KB	Share
OSX	Application for quotation of securities - OSX		04/01/23	24.96KB	Share
OSX	Notification of cessation of securities - OSX		03/01/23	21.98KB	Share
OSX	Reinstatement to Official Quotation	PRICE SENSITIVE	22/12/22	404.26KB	Share
OSX	Proposed issue of securities - OSX		22/12/22	37.31KB	Share
OSX	Firm Commitments and Non-Binding Proposed Acquisition	PRICE SENSITIVE	22/12/22	258.31KB	Share
OSX	Suspension from Official Quotation	PRICE SENSITIVE	21/12/22	561.44KB	Share
OSX	Trading Halt	PRICE SENSITIVE	19/12/22	639.28KB	Share
OSX	Increased presence and commercial opportunities across SEA	PRICE SENSITIVE	08/12/22	483.33KB	Share
OSX	Activities Update Qtr Ending September 2022 and Appendix 4C	PRICE SENSITIVE	31/10/22	516.48KB	Share
OSX	Ceasing to be a substantial holder		05/10/22	81.33KB	Share
OSX	Change in substantial holding		05/10/22	222.64KB	Share
OSX	Chile Government and University co-fund Osteopore research		28/09/22	279.99KB	Share
OSX	More Osteopore Products Available on Prostheses List		28/09/22	243.9KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/22	752.78KB	Share
OSX	Change in substantial holding		24/08/22	270.95KB	Share
OSX	Becoming a substantial holder		24/08/22	142.64KB	Share
OSX	Osteopore Moves Closer to China Market Entry	PRICE SENSITIVE	23/08/22	247.2KB	Share
OSX	Investor Presentation		10/08/22	7.76MB	Share
OSX	Osteopore Gains Access to US Federal Healthcare Facilities		03/08/22	242.12KB	Share
OSX	SHG: Clarification regarding collaboration with OSX		02/08/22	528.57KB	Share
OSX	SHG: Collaborative Agreement signed with OSX		01/08/22	758.77KB	Share
OSX	Osteopore to Leverage on AI/VR to Enhance Market Access		01/08/22	424.03KB	Share
OSX	Activities Update Qtr Ending June 2022 and Appendix 4C	PRICE SENSITIVE	25/07/22	776.56KB	Share
OSX	Notification of cessation of securities - OSX		04/07/22	21.56KB	Share
OSX	Change of Director's Interest Notice		01/07/22	279.14KB	Share
OSX	Collaboration With Healthcare Group To Develop New Products		20/06/22	225.32KB	Share
OSX	Change of Director's Interest Notice		15/06/22	199.9KB	Share
OSX	OSX Expands into Africa with Initial Sales to South Africa		14/06/22	207.95KB	Share
OSX	Constitution		01/06/22	674.04KB	Share
OSX	Employee Securities Incentive Plan		01/06/22	221.72KB	Share
OSX	Results of Annual General Meeting		31/05/22	188.96KB	Share
OSX	OSX Enter Oral & Maxillofacial Market in Australia & NZ	PRICE SENSITIVE	10/05/22	407.05KB	Share
OSX	Notice of Annual General Meeting		29/04/22	1.04MB	Share
OSX	Activities Update Qtr Ending March 2022 and Appendix 4C	PRICE SENSITIVE	29/04/22	1.06MB	Share
OSX	Appointment of Chief Operating Officer		28/04/22	214.43KB	Share
OSX	OSX Expands Further into Europe with Initial Sales to Spain		14/04/22	439.67KB	Share
OSX	Annual General Meeting Date		07/04/22	218.14KB	Share
OSX	OSX Expands to Latin America with Initial Sales to Colombia		07/04/22	612.31KB	Share
OSX	Appendix 4G and Corporate Governance Statement		31/03/22	424.27KB	Share
OSX	Annual Report to shareholders		31/03/22	1.7MB	Share
OSX	OSX Commences AI-Powered Design Study for Cranial Implants		14/03/22	253.05KB	Share
OSX	SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures	PRICE SENSITIVE	14/03/22	341.79KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/22	256.14KB	Share
OSX	Notification of cessation of securities - OSX		25/02/22	21.54KB	Share
OSX	Appendix 3Y		25/02/22	351.12KB	Share
OSX	Appendix 3Z		15/02/22	227.19KB	Share
OSX	Resignation of Non-Executive Director		15/02/22	213.75KB	Share
OSX	Activities Update Qtr Ending December 2021 and Appendix 4C	PRICE SENSITIVE	28/01/22	503.6KB	Share
OSX	Chief Financial Officer Resignation		18/01/22	199.88KB	Share
OSX	Appendix 3X		29/12/21	225.25KB	Share
OSX	Change to the Board of Directors		29/12/21	233.1KB	Share
OSX	Osteopore secures A$19m clinical-industrial partnership	PRICE SENSITIVE	13/12/21	270.16KB	Share
OSX	Osteopore Receives Approval for Hong Kong Sales		02/12/21	236.86KB	Share
OSX	Investor Presentation		22/11/21	3.71MB	Share
OSX	Osteopore granted patent in China opening local opportunity		02/11/21	298.25KB	Share
OSX	Activities Update Qtr Ending September 2021 and Appendix 4C	PRICE SENSITIVE	29/10/21	547.06KB	Share
OSX	Osteopore collaborates with Singular Health Group		19/10/21	283.58KB	Share
OSX	SHG: CSIRO Collaboration for AI-based Tool	PRICE SENSITIVE	19/10/21	236.57KB	Share
OSX	Appendix 3X and Appendix 3Zs		13/10/21	482.79KB	Share
OSX	Changes to Board of Directors		08/10/21	209.37KB	Share
OSX	Application for quotation of securities - OSX		23/09/21	34.11KB	Share
OSX	Notice of Release from Escrow		16/09/21	162.13KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/21	1MB	Share
OSX	Osteopore Sponsors Australian Patient Trials		26/08/21	263.02KB	Share
OSX	Appendix 3X and Appendix 3Z		06/08/21	408.47KB	Share
OSX	Changes to Osteopore Board of Directors		02/08/21	208.45KB	Share
OSX	Activities Update Qtr Ending June 2021 and Appendix 4C	PRICE SENSITIVE	30/07/21	547.07KB	Share
OSX	Change in substantial holding		16/07/21	338.84KB	Share
OSX	Notification regarding unquoted securities - OSX		02/07/21	27.17KB	Share
OSX	Investor Presentation		10/06/21	3.94MB	Share
OSX	Results of Annual General Meeting		28/05/21	187.62KB	Share
OSX	AGM Teleconference Details		14/05/21	205.56KB	Share
OSX	Osteopore Expanded CE Listing		10/05/21	249.08KB	Share
OSX	Activities Update Qtr Ending March 2021 and Appendix 4C	PRICE SENSITIVE	30/04/21	530.66KB	Share
OSX	Notice of Annual General Meeting		29/04/21	660.47KB	Share
OSX	Osteopore Granted Patent for Smart 3D Biomimetic Scaffolds		27/04/21	251.59KB	Share
OSX	Annual General Meeting Date		01/04/21	184.97KB	Share
OSX	Appendix 4G and Corporate Governance Statement		25/03/21	599.17KB	Share
OSX	Annual Report to shareholders		25/03/21	2.21MB	Share
OSX	Investor Presentation		22/03/21	8.72MB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	26/02/21	273.95KB	Share
OSX	Agreement with Terumo Blood and Cell Technologies	PRICE SENSITIVE	01/02/21	241.21KB	Share
OSX	Activities Update Qtr Ending December 2020 and Appendix 4C	PRICE SENSITIVE	29/01/21	615.69KB	Share
OSX	Change in substantial holding forms		21/12/20	348.23KB	Share
OSX	Investor Presentation		24/11/20	988.51KB	Share

OSX Letter to Optionholders
13/03/23		152.5KB	Share
OSX Letter to Ineligible Shareholders
13/03/23		151.86KB	Share
OSX Proposed issue of securities - OSX
13/03/23		43.84KB	Share
OSX Letter to Eligible Shareholders
13/03/23		165.99KB	Share
OSX Non-Renounceable Entitlement Offer Prospectus
13/03/23	PRICE SENSITIVE	655.44KB	Share
OSX Non-Renounceable Entitlement Offer
13/03/23	PRICE SENSITIVE	225.78KB	Share
OSX Notice of General Meeting/Proxy Form
02/03/23		985.97KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/23	PRICE SENSITIVE	214.39KB	Share
OSX Osteopore Advisory Panel of Distinguished Industry Leaders
27/02/23		318.18KB	Share
OSX Investor Presentation
20/02/23		6.22MB	Share
OSX OSX Enters Orthopaedic Market in Great Britain
14/02/23		233.78KB	Share
OSX Activities Update Qtr Ending December 2022 and Appendix 4C
31/01/23	PRICE SENSITIVE	619.31KB	Share
OSX Appointment of Joint Company Secretary
25/01/23		165.42KB	Share
OSX Integration of Acquired Business for Higher Sales & Margin
23/01/23	PRICE SENSITIVE	269.81KB	Share
OSX Cleansing Notice
04/01/23		222.94KB	Share
OSX Application for quotation of securities - OSX
04/01/23		24.96KB	Share
OSX Notification of cessation of securities - OSX
03/01/23		21.98KB	Share
OSX Reinstatement to Official Quotation
22/12/22	PRICE SENSITIVE	404.26KB	Share
OSX Proposed issue of securities - OSX
22/12/22		37.31KB	Share
OSX Firm Commitments and Non-Binding Proposed Acquisition
22/12/22	PRICE SENSITIVE	258.31KB	Share
OSX Suspension from Official Quotation
21/12/22	PRICE SENSITIVE	561.44KB	Share
OSX Trading Halt
19/12/22	PRICE SENSITIVE	639.28KB	Share
OSX Increased presence and commercial opportunities across SEA
08/12/22	PRICE SENSITIVE	483.33KB	Share
OSX Activities Update Qtr Ending September 2022 and Appendix 4C
31/10/22	PRICE SENSITIVE	516.48KB	Share
OSX Ceasing to be a substantial holder
05/10/22		81.33KB	Share
OSX Change in substantial holding
05/10/22		222.64KB	Share
OSX Chile Government and University co-fund Osteopore research
28/09/22		279.99KB	Share
OSX More Osteopore Products Available on Prostheses List
28/09/22		243.9KB	Share
OSX Half Yearly Report and Accounts
31/08/22	PRICE SENSITIVE	752.78KB	Share
OSX Change in substantial holding
24/08/22		270.95KB	Share
OSX Becoming a substantial holder
24/08/22		142.64KB	Share
OSX Osteopore Moves Closer to China Market Entry
23/08/22	PRICE SENSITIVE	247.2KB	Share
OSX Investor Presentation
10/08/22		7.76MB	Share
OSX Osteopore Gains Access to US Federal Healthcare Facilities
03/08/22		242.12KB	Share
OSX SHG: Clarification regarding collaboration with OSX
02/08/22		528.57KB	Share
OSX SHG: Collaborative Agreement signed with OSX
01/08/22		758.77KB	Share
OSX Osteopore to Leverage on AI/VR to Enhance Market Access
01/08/22		424.03KB	Share
OSX Activities Update Qtr Ending June 2022 and Appendix 4C
25/07/22	PRICE SENSITIVE	776.56KB	Share
OSX Notification of cessation of securities - OSX
04/07/22		21.56KB	Share
OSX Change of Director's Interest Notice
01/07/22		279.14KB	Share
OSX Collaboration With Healthcare Group To Develop New Products
20/06/22		225.32KB	Share
OSX Change of Director's Interest Notice
15/06/22		199.9KB	Share
OSX OSX Expands into Africa with Initial Sales to South Africa
14/06/22		207.95KB	Share
OSX Constitution
01/06/22		674.04KB	Share
OSX Employee Securities Incentive Plan
01/06/22		221.72KB	Share
OSX Results of Annual General Meeting
31/05/22		188.96KB	Share
OSX OSX Enter Oral & Maxillofacial Market in Australia & NZ
10/05/22	PRICE SENSITIVE	407.05KB	Share
OSX Notice of Annual General Meeting
29/04/22		1.04MB	Share
OSX Activities Update Qtr Ending March 2022 and Appendix 4C
29/04/22	PRICE SENSITIVE	1.06MB	Share
OSX Appointment of Chief Operating Officer
28/04/22		214.43KB	Share
OSX OSX Expands Further into Europe with Initial Sales to Spain
14/04/22		439.67KB	Share
OSX Annual General Meeting Date
07/04/22		218.14KB	Share
OSX OSX Expands to Latin America with Initial Sales to Colombia
07/04/22		612.31KB	Share
OSX Appendix 4G and Corporate Governance Statement
31/03/22		424.27KB	Share
OSX Annual Report to shareholders
31/03/22		1.7MB	Share
OSX OSX Commences AI-Powered Design Study for Cranial Implants
14/03/22		253.05KB	Share
OSX SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures
14/03/22	PRICE SENSITIVE	341.79KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/22	PRICE SENSITIVE	256.14KB	Share
OSX Notification of cessation of securities - OSX
25/02/22		21.54KB	Share
OSX Appendix 3Y
25/02/22		351.12KB	Share
OSX Appendix 3Z
15/02/22		227.19KB	Share
OSX Resignation of Non-Executive Director
15/02/22		213.75KB	Share
OSX Activities Update Qtr Ending December 2021 and Appendix 4C
28/01/22	PRICE SENSITIVE	503.6KB	Share
OSX Chief Financial Officer Resignation
18/01/22		199.88KB	Share
OSX Appendix 3X
29/12/21		225.25KB	Share
OSX Change to the Board of Directors
29/12/21		233.1KB	Share
OSX Osteopore secures A$19m clinical-industrial partnership
13/12/21	PRICE SENSITIVE	270.16KB	Share
OSX Osteopore Receives Approval for Hong Kong Sales
02/12/21		236.86KB	Share
OSX Investor Presentation
22/11/21		3.71MB	Share
OSX Osteopore granted patent in China opening local opportunity
02/11/21		298.25KB	Share
OSX Activities Update Qtr Ending September 2021 and Appendix 4C
29/10/21	PRICE SENSITIVE	547.06KB	Share
OSX Osteopore collaborates with Singular Health Group
19/10/21		283.58KB	Share
OSX SHG: CSIRO Collaboration for AI-based Tool
19/10/21	PRICE SENSITIVE	236.57KB	Share
OSX Appendix 3X and Appendix 3Zs
13/10/21		482.79KB	Share
OSX Changes to Board of Directors
08/10/21		209.37KB	Share
OSX Application for quotation of securities - OSX
23/09/21		34.11KB	Share
OSX Notice of Release from Escrow
16/09/21		162.13KB	Share
OSX Half Yearly Report and Accounts
31/08/21	PRICE SENSITIVE	1MB	Share
OSX Osteopore Sponsors Australian Patient Trials
26/08/21		263.02KB	Share
OSX Appendix 3X and Appendix 3Z
06/08/21		408.47KB	Share
OSX Changes to Osteopore Board of Directors
02/08/21		208.45KB	Share
OSX Activities Update Qtr Ending June 2021 and Appendix 4C
30/07/21	PRICE SENSITIVE	547.07KB	Share
OSX Change in substantial holding
16/07/21		338.84KB	Share
OSX Notification regarding unquoted securities - OSX
02/07/21		27.17KB	Share
OSX Investor Presentation
10/06/21		3.94MB	Share
OSX Results of Annual General Meeting
28/05/21		187.62KB	Share
OSX AGM Teleconference Details
14/05/21		205.56KB	Share
OSX Osteopore Expanded CE Listing
10/05/21		249.08KB	Share
OSX Activities Update Qtr Ending March 2021 and Appendix 4C
30/04/21	PRICE SENSITIVE	530.66KB	Share
OSX Notice of Annual General Meeting
29/04/21		660.47KB	Share
OSX Osteopore Granted Patent for Smart 3D Biomimetic Scaffolds
27/04/21		251.59KB	Share
OSX Annual General Meeting Date
01/04/21		184.97KB	Share
OSX Appendix 4G and Corporate Governance Statement
25/03/21		599.17KB	Share
OSX Annual Report to shareholders
25/03/21		2.21MB	Share
OSX Investor Presentation
22/03/21		8.72MB	Share
OSX Appendix 4E Preliminary Final Report
26/02/21	PRICE SENSITIVE	273.95KB	Share
OSX Agreement with Terumo Blood and Cell Technologies
01/02/21	PRICE SENSITIVE	241.21KB	Share
OSX Activities Update Qtr Ending December 2020 and Appendix 4C
29/01/21	PRICE SENSITIVE	615.69KB	Share
OSX Change in substantial holding forms
21/12/20		348.23KB	Share
OSX Investor Presentation
24/11/20		988.51KB	Share

REFRESH

First 2

(20min delay)
Last 37.5¢		Change 0.075(25.0%)		Mkt cap ! $3.873M

Open	High	Low	Value	Volume
32.0¢	38.0¢	32.0¢	$44.88K	123.4K

Buyers (Bids)

No.	Vol.	Price($)
1	6178	35.0¢

Sellers (Offers)

Price($)	Vol.	No.
37.5¢	2556	1

View Market Depth

No.	Vol.	Price($)
1	6178	0.350
1	2500	0.340
1	156000	0.320
2	14000	0.305
3	9374	0.300

Price($)	Vol.	No.
0.375	2556	1
0.380	2200	2
0.395	2500	1
0.400	255991	2
0.420	2000	1

Last trade - 15.58pm 03/05/2024 (20 minute delay)

OSX (ASX) Chart

OSTEOPORE LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available